DREAMing About Dry Eye

Penny A. Asbell, MD, MBA, FACS

Show Description +

An estimated $1 billion in revenue each year is generated from the sale of omega-3 supplements, but the results of the Dry Eye Assessment and Management (DREAM) Study have been surprising to many. Penny A. Asbell, MD, MBA, FACS, led the NIH-sponsored trial which followed for 1 year more than 500 patients with signs and symptoms of DED, randomized to receive either 3 g/day oral omega-3 or 5 g/day olive oil. Watch as Dr. Asbell shares the findings from this study.

Posted: 4/10/2018

Keywords:

DREAM

•

Dry Eye

Up Next

Diving Into MIGS

Davinder S. Grover, MD

Man Meets Machine: Technology and Glaucoma

Arsham Sheybani, MD, Inder Paul Singh, MD, Iqbal Ike K. Ahmed, MD, FRCSC

New Kids on the Block: Novel Glaucoma Drops

Jacob W. Brubaker, MD

Glaucoma and Uveitis

Ramya Swamy, MD

The Future of Sustained-Release Glaucoma Drugs

Devesh K. Varma, MD

Hot Topic: Artificial Intelligence and Big Data in Ophthalmology

Jai G. Parekh, MD, MBA, Michael D. Abramoff, MD, PhD, Richard M. Awdeh, MD

Choosing the Right IOL

Steven J. Dell, MD

How to Prevent and Manage Negative Dysphotopsia

Nicole R. Fram, MD

Corneal Topography: What You Need to Know

William B. Trattler, MD

A Tale of Two Studies: Omega-3s and Dry Eye

Alice T. Epitropoulos, MD

Hot Topic: Results of the DREAM study

Eric D. Donnenfeld, MD, John D. Sheppard, MD, Lisa M. Nijm, MD, JD, Marguerite McDonald, MD

Anesthesia Services Not Covered for Cataract Surgery

Michael Patterson, DO, Shachar Tauber, MD, Tal Raviv, MD

Big Changes in the Corneal Inlay Marketplace

George O. Waring IV, MD, James A. Katz, MD

Advantages of the IC-8 IOL

Jay S. Pepose, MD, PhD

Accurate Corneal Astigmatism Measurements

Noel Alpins, AM, MBBS, DO (Melb), FRANZCO, FRACS, FRCOphth, FACS

Toric IOLs May Help Glaucoma Patients Maximize Vision

Beverly Busse, BS

Celebrating the 30th Anniversary of LASIK

Eric D. Donnenfeld, MD, Marguerite McDonald, MD, FACS, Robert K. Maloney, MD

Practical Tools to Utilize OCT for Glaucoma Cases

Brian A. Francis, MD, MS

To YAG or Not to YAG?

Richard Tipperman, MD

Anterior-Segment OCT for Glaucoma

Vikas Chopra, MD

Master Complicated Cataract Cases

Lisa M. Nijm, MD, JD

Hot Topic: The Future of Ophthalmic Education

Gregory D. Parkhurst, MD, FACS, Robert J. Weinstock, MD, Sumit "Sam" Garg, MD, Zaina Al-Mohtaseb, MD

Preventing Ectasia: Is It Possible?

Steven C. Schallhorn, MD

The Challenge of Choosing the Right IOL Power

Oliver Findl, MD, MBA

Back to All Videos

DREAMing About Dry Eye

Penny A. Asbell, MD, MBA, FACS

Posted: 4/10/2018

Keywords:

DREAM

•

Dry Eye

Please log in to leave a comment.

Comments

Anonymous

7 years ago

Study shows that either 3g omega or 5g olive oil produce better results than cyclosporin in most patients. I suggest to recommend omega 3 or olive oil for dry eyes.

Anonymous

7 years ago

olive oil is a strong antiiflammatory..cannot use it as placebo. The study is like comparing low dose voltaren with high dose nurofen and finding not significant difference between them and conclude that voltaren does not work!!Why they have not mentioned the inflammatory markers eg MMP-9 in the 2 groups?? Why they choose only 2g of EPA?Did they check on mice model to decide on the best dose of omega 3??Why only 1g of DHA??

Ugur Altiparmak

7 years ago

should we suggest 5 g olive oil rather than omega-3?

Anonymous

7 years ago

Thank you for conducting this trial Please help clarify what type of omega-3 was used in this study: (TG) Triglyceride type or (EE) Ethyl Ester type ?

Meeting Coverage:

American Society of Cataract and Refractive Surgery Meeting

DREAMing About Dry Eye

Up Next

DREAMing About Dry Eye

Comments

More From ASCRS: 2018 Coverage